Danone US, LLC of Louisville, CO, is recalling 75,654 bottles of two International Delight Coffee Creamer flavors because of spoilage and associated consumer illness complaints.
According to details published online by the Food and Drug Administration (FDA), the recall was initiated on Feb. 21, 2025, and remains ongoing. The firm voluntarily launched the recall after receiving reports of spoilage and illness linked to the products, which have been classified as a Class II risk. This classification indicates a low probability of serious health consequences but a potential for temporary or reversible effects.
The recalled coffee creamers were distributed to retail locations across 31 states: Alabama, Arkansas, Colorado, Connecticut, Florida, Georgia, Illinois, Indiana, Kentucky, Louisiana, Maryland, Maine, Michigan, Minnesota, Missouri, Mississippi, North Carolina, Nebraska, New Hampshire, New Jersey, New Mexico, New York, Ohio, Oklahoma, Pennsylvania, South Carolina, Tennessee, Texas, Virginia, Wisconsin and Wyoming.
Recalled Products:
Hazelnut International Delight Coffee Creamer
- Item Description: 32 fl oz (1 qt), 946 mL
- UPC: 0 41271 02565 2
- Code Information: BEST BY: 02 JUL 2025 51-4114 R-S
- Product Quantity: 4,762 cases (6 bottles per case, totaling 28,572 bottles)
- Recall Number: F-0626-2025
Cinnabon Classic Cinnamon Roll International Delight Coffee Creamer
- Item Description: 32 fl oz (1 qt), 946 mL
- UPC: 0 41271 01993 3
- Code Information: BEST BY: 03 JUL 2025 51-4114 R-S
- Product Quantity: 7,747 cases (6 bottles per case, totaling 46,482 bottles)
- Recall Number: F-0625-2025
Retailers and consumers should not use, sell, serve, or distribute the affected products.
About spoilage and illness concerns
Spoilage in coffee creamers can result from microbial contamination or product degradation, potentially leading to off-flavors, odors, or textures. The firm received consumer complaints linking the use of these products to illness, though specific symptoms were not detailed in the recall notice.
A Class II classification suggests that any adverse effects are likely temporary or reversible, but consumers experiencing unusual symptoms—such as nausea, digestive discomfort, or other reactions—after using these products should seek medical attention promptly.
Disclaimer
The information contained in South Florida Reporter is for general information purposes only.
The South Florida Reporter assumes no responsibility for errors or omissions in the contents of the Service.
In no event shall the South Florida Reporter be liable for any special, direct, indirect, consequential, or incidental damages or any damages whatsoever, whether in an action of contract, negligence or other tort, arising out of or in connection with the use of the Service or the contents of the Service. The Company reserves the right to make additions, deletions, or modifications to the contents of the Service at any time without prior notice.
The Company does not warrant that the Service is free of viruses or other harmful components
This article originally appeared here and was republished with permission.
